EMIATEuropean Myocardial Infarction Amiodarone Trial
References in periodicals archive ?
With outbound deals having outnumbered inbound deals for the last three consecutive six-month periods, India seems on its way to becoming a net "deal exporter" in the next EMIAT study slated for early 2009.
Since the EMIAT study's inception in 2003, the total number of acquisitions made by India-based companies in developed economies (322) is close to surpassing the total number of completed acquisitions that companies from developed countries made in India (340).
Among other key survey findings: -- With Central & Eastern Europe newly introduced into the EMIAT, the region immediately established itself as the emerging market destination of choice (996 D2E deals over the past six years).
Wyeth-Ayerst is very pleased by the consistency of the results of EMIAT and CAMIAT.
Cordarone has been used successfully for many years to prevent life-threatening refractory cardiac arrhythmias, but EMIAT and CAMIAT are the first large, well-controlled clinical trials to demonstrate that Cordarone favorably affects outcome in patients who have recently sustained a myocardial infarction and who have ventricular arrhythmias or poor left ventricular function.
KPMG said that with outbound deals now having outnumbered inbound deals for each of the last three six-month periods, India now seemed well set to become a net 'deal exporter' in the next EMIAT in 2009.
Becoming a net exporter of deals within the EMIAT - when it happens - is a credible enough achievement in its own right.
All raw data within the EMIAT is sourced from Thomson Reuters SDC.
While it remains to be seen whether we will see deal volumes at pre-crisis levels in the near future, the current EMIAT data suggests that there is still the appetite for the right deal, in the right market, at the right time.
Japan, Germany, Australia and Canada continue to rise and are at or above previous levels - Japan and Canada at 61 and 82 deals respectively, have hit their highest ever level in the eight years of the EMIAT.
Since the second half of 2006, when E2D deals represented 23 percent of the D2E total, that gap has been steadily closing to stand at 47 percent In the most recent EMIAT.
Looking back over the five year period covered by the current EMIAT, 1022 E2D deals have been recorded, with Indian trade buyers accounting for largest share by far.